Quest Diagnostics Inc DGX:NYSE (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 58.81 | 0.88 1.52% | 2.24% | 1,071,663 | 1.6M |
Latest News Headlines for Quest Diagnostics Inc
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In April 2014, the Company announced the acquisition of Summit Health. Combined business will be referred to as Quest Diagnostics Health and Wellness Services.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 58.53 |
| Previous Close | 57.93 |
| Day High | 58.99 |
| Day Low | 58.33 |
| 52 Week High | 9/3/2014 | 64.38 |
| 52 Week Low | 2/7/2014 | 50.46 |
| % Off 52 Week High | -8.65% |
| % Off 52 Week Low | 16.55% |
| Beta (5 Yr) | 0.8 |
| Volatility Avg | 10/17/2014 | 18.34 |
| 10-Day Avg. Volume | 1,605,576 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 5.25 |
|---|---|
| P/E Ratio | 6/30/2014 | 11.2 |
| Market Cap | Mid Cap | 8.5B |
| Shares Outstanding | 144.42M |
| Float | 143.9M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | 2.24% |
|---|---|
| Ex-Date | 10/3/2014 |
| Dividend Announcement | 8/15/2014 |
| Date of Record | 10/7/2014 |
| Payable | $0.33 - QRTR |
| Payable Date | 10/22/2014 |
Peers Information HelpDGX Quest Diagnostics Inc vs. Peers
| Peers | |
|---|---|
DGX Quest Diagnostics Inc | 9.84% |
Laboratory Corp. of America Holdings | 7.99% |
Bio-Reference Laboratories Inc | 10.57% |
Ventas, Inc. | 15.94% |
Johnson & Johnson | 7.76% |
DGX Quest Diagnostics Inc | 2.24% |
Laboratory Corp. of America Holdings | -- |
Bio-Reference Laboratories Inc | -- |
Ventas, Inc. | 4.37% |
Johnson & Johnson | 2.84% |
DGX Quest Diagnostics Inc | 1.52% |
Laboratory Corp. of America Holdings | 0.67% |
Bio-Reference Laboratories Inc | -0.70% |
Ventas, Inc. | 0.39% |
Johnson & Johnson | 1.98% |